Dr. Sung Kwon

Claim this profile

Holy Name Hospital

Studies Pancreatic Cancer
Studies Pancreatic Carcinoma
2 reported clinical trials
25 drugs studied

Area of expertise

1

Pancreatic Cancer

Sung Kwon has run 2 trials for Pancreatic Cancer. Some of their research focus areas include:

Stage III
Stage IV
2

Pancreatic Carcinoma

Sung Kwon has run 1 trial for Pancreatic Carcinoma.

Affiliated Hospitals

Image of trial facility.

Holy Name Hospital

Image of trial facility.

Roger Williams Medical Center

Clinical Trials Sung Kwon is currently running

Image of trial facility.

Perioperative Chemotherapy

for Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).

Recruiting

4 awards

Phase 3

18 criteria

Image of trial facility.

Targeted Therapy

for Solid Tumors

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.

Recruiting

1 award

Phase 2

17 criteria

More about Sung Kwon

Clinical Trial Related

5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Sung Kwon has experience with

  • Fluorouracil
  • Oxaliplatin
  • Irinotecan Hydrochloride
  • Leucovorin Calcium
  • Resection
  • Binimetinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Sung Kwon specialize in?

Is Sung Kwon currently recruiting for clinical trials?

Are there any treatments that Sung Kwon has studied deeply?

What is the best way to schedule an appointment with Sung Kwon?

What is the office address of Sung Kwon?

Is there any support for travel costs?